Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Chen

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|October 20, 2009
The yin and yang of paracetamol and paediatric immunisationsRobert T Chen, Thomas A Clark, Scott A Halperin
Bulletin of the World Health Organization|December 14, 2002
Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan AfricaDonatus U Ekwueme, Bruce G Weniger, Robert T Chen
Vaccine|July 19, 2011
Modeling the impact of RV144-like vaccines on HIV transmissionCatherine A Hankins, John W Glasser, Robert T Chen
Vaccine|October 17, 2017
Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?Hector S Izurieta, Pedro L Moro, Robert T Chen
Pediatric Annals|October 7, 2004
The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safetyJohn K Iskander, Elaine R Miller, Robert T Chen
Journal of the International Association of Providers of AIDS Care|June 6, 2014
Medical risks and benefits of newborn male circumcision in the United States: physician perspectivesLea Matar, Julia Zhu, Robert T Chen, et al.
Vaccine|August 25, 2016
Obstetrical and neonatal case definitions for immunization safety dataRobert T Chen, Pedro L Moro, Jorgen Bauwens, et al.
BMJ (Clinical Research Ed.)|July 14, 2011
Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccinesFrank DeStefano, Claudia Vellozzi, Lawrence B Schonberger, et al.
Expert Opinion on Drug Safety|February 12, 2024
Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety programDaniel A Salmon, Robert T Chen, Steve Black, et al.
Expert Review of Clinical Immunology|September 28, 2013
Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?Daniel A Salmon, Claudia Vellozzi, Robert T Chen, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|October 20, 2009
The yin and yang of paracetamol and paediatric immunisationsRobert T Chen, Thomas A Clark, Scott A Halperin
Bulletin of the World Health Organization|December 14, 2002
Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan AfricaDonatus U Ekwueme, Bruce G Weniger, Robert T Chen
Vaccine|July 19, 2011
Modeling the impact of RV144-like vaccines on HIV transmissionCatherine A Hankins, John W Glasser, Robert T Chen
Vaccine|October 17, 2017
Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?Hector S Izurieta, Pedro L Moro, Robert T Chen
Pediatric Annals|October 7, 2004
The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safetyJohn K Iskander, Elaine R Miller, Robert T Chen
Journal of the International Association of Providers of AIDS Care|June 6, 2014
Medical risks and benefits of newborn male circumcision in the United States: physician perspectivesLea Matar, Julia Zhu, Robert T Chen, et al.
Vaccine|August 25, 2016
Obstetrical and neonatal case definitions for immunization safety dataRobert T Chen, Pedro L Moro, Jorgen Bauwens, et al.
BMJ (Clinical Research Ed.)|July 14, 2011
Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccinesFrank DeStefano, Claudia Vellozzi, Lawrence B Schonberger, et al.
Expert Opinion on Drug Safety|February 12, 2024
Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety programDaniel A Salmon, Robert T Chen, Steve Black, et al.
Expert Review of Clinical Immunology|September 28, 2013
Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?Daniel A Salmon, Claudia Vellozzi, Robert T Chen, et al.
Pageof 12